Detalhe da pesquisa
1.
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.
Mol Ther
; 31(2): 471-486, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35965411
2.
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients.
Br J Haematol
; 203(4): 625-636, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691342
3.
Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma.
Br J Clin Pharmacol
; 88(5): 2096-2117, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709655
4.
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patients.
CPT Pharmacometrics Syst Pharmacol
; 12(11): 1795-1803, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011601
5.
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Cancer Chemother Pharmacol
; 2023 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957436
6.
Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption.
Pharmaceutics
; 14(7)2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35890391
7.
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis.
Cancer Chemother Pharmacol
; 90(1): 29-44, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751658
8.
Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351.
J Control Release
; 338: 244-252, 2021 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416320